| Dr Tyler Ryan Teichmeier, MD | |
|
5440 South St Ste 200, Lincoln, NE 68506-2116 | |
| (402) 465-1900 | |
| Not Available |
| Full Name | Dr Tyler Ryan Teichmeier |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 9 Years |
| Location | 5440 South St Ste 200, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083095186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 31303 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health St. Elizabeth | Lincoln, NE | Hospital |
| Bryan Medical Center | Lincoln, NE | Hospital |
| Faith Regional Health Services | Norfolk, NE | Hospital |
| Columbus Community Hospital | Columbus, NE | Hospital |
| Chi Health Nebraska Heart | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Platte Nebraska Hospital Corporation | 6507856697 | 181 |
| Pathology Medical Services Pc | 0648255265 | 10 |
News Archive
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Once considered a hospital anomaly, community-acquired infections with drug-resistant strains of the bacterium Staphylococcus aureus now turn up regularly among children hospitalized in the intensive-care unit, according to research from the Johns Hopkins Children's Center.
GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.
Cerebral Palsy Family Network has released a video showing children and teens with cerebral palsy delighting in playing video games using a new technology. The players, some with visual impairment, used gestures instead of keyboards.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
› Verified 6 days ago
| Entity Name | North Platte Nebraska Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700855533 PECOS PAC ID: 6507856697 Enrollment ID: O20040512000889 |
News Archive
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Once considered a hospital anomaly, community-acquired infections with drug-resistant strains of the bacterium Staphylococcus aureus now turn up regularly among children hospitalized in the intensive-care unit, according to research from the Johns Hopkins Children's Center.
GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.
Cerebral Palsy Family Network has released a video showing children and teens with cerebral palsy delighting in playing video games using a new technology. The players, some with visual impairment, used gestures instead of keyboards.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
› Verified 6 days ago
| Entity Name | Pathology Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851455646 PECOS PAC ID: 0648255265 Enrollment ID: O20041022000417 |
News Archive
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Once considered a hospital anomaly, community-acquired infections with drug-resistant strains of the bacterium Staphylococcus aureus now turn up regularly among children hospitalized in the intensive-care unit, according to research from the Johns Hopkins Children's Center.
GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.
Cerebral Palsy Family Network has released a video showing children and teens with cerebral palsy delighting in playing video games using a new technology. The players, some with visual impairment, used gestures instead of keyboards.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tyler Ryan Teichmeier, MD 5440 South St Ste 200, Lincoln, NE 68506-2116 Ph: (402) 465-1900 | Dr Tyler Ryan Teichmeier, MD 5440 South St Ste 200, Lincoln, NE 68506-2116 Ph: (402) 465-1900 |
News Archive
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Once considered a hospital anomaly, community-acquired infections with drug-resistant strains of the bacterium Staphylococcus aureus now turn up regularly among children hospitalized in the intensive-care unit, according to research from the Johns Hopkins Children's Center.
GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.
Cerebral Palsy Family Network has released a video showing children and teens with cerebral palsy delighting in playing video games using a new technology. The players, some with visual impairment, used gestures instead of keyboards.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
› Verified 6 days ago
Dr. Aina Inese Silenieks, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Matthias I Okoye, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-486-3447 Fax: 402-486-3477 | |
Dr. Deborah Kay Davidson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Jon R Steinhauer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Dr. Neil E. Fuehrer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1973 | |
Dr. Charles Meehan Reese, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 |